Skip to content

Public FDA record

Z-1398-2023: REX (Recovery Exercise X-Trainer) Pressure Therapy System- USER Manual. Intended to temporarily relieve m

Recall record Z-1398-2023 for Compass Health Brands (Corporate Office). View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1398-2023
Company in FDA record
Compass Health Brands (Corporate Office)
FDA classification date
Apr 18, 2023
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Error in the Introduction section of the user manual that indicates the device may be used for the prevention of deep vein thrombosis (DVT). Marketed without a 510k for this indication

Source facts

Action
Compass Health Brands issued Urgent Medical Device Recall Letter REX (Recovery Exercise Trainer) Pressure Therapy System - USER MANUAL on 3/7/23 via Email/US Mail notification to Distributors and End Users consignees and posted to the Compass Health Brands website http://www.compasshealthbrands.com. Letter states reason for recall, health risk and action to take: Immediately replace the current user manual included with the device with the attached, corrected version, and dispose of the current manual. Compass Health Brands will additionally mail you a replacement user Consumer Notification manual in booklet format (which is the same format as the current user manual), if you prefer to use that as a replacement, instead. REQUIRED ACTION: 1. The USER MANUAL for the REX (Recovery Exercise Trainer) Pressure Therapy System requires replacement. Visit https://compasshealthbrands.com/product-recall to obtain a replacement user manual, or Contact Compass Health Brands at (800) 947-1728 to order a replacement user manual in booklet format, or Indicate on your Reply Form (attached) that you would like a replacement user manual. 2. Complete and return the attached Consumer Field Correction Response Form to Compass Health Brands within fifteen (15) calendar days of receipt of this field correction notification confirming your acknowledgement. Send completed form to Compass Health Brands via email at regulatory@compasshealthbrands.com. Complete and return this form even if you do not have affected product on hand. If you have transferred possession of this product to another individual/department/location, please notify them of this recall communication. This voluntary Field Correction notification is being conducted with the knowledge of the United States Food and Drug Administration (FDA) in accordance with U.S. regulations. Any complaints and/or adverse events experienced with the use of this product must be reported promptly to Compass Health Brands Customer Suppor
Initiated
2023-03-07
Root cause
Labeling design
Distribution
Worldwide distribution - US Nationwide and the country of Canada.
Recall number
Z-1398-2023
Recall status
Open, Classified
CDRH record ID
199221
FDA classified
2023-04-18
Recall event number
91923

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗